Liv Pure Peptide Product: Igf-1lr3

Liv Pure Peptides Igf-1lr3 (IGF‑1 LR3) Categories: Fitness & Performance, Recovery & Healing $99.99 CAS# 946870-92-4 Formula: C400H625N111O115S9 Molecular Weight: 9117.500 g/mol

Receptor Grade IGF-1 LR3 is a modified synthetic analog of human Insulin-like Growth Factor-1, engineered with a 13-amino acid N-terminal extension and an arginine substitution at position 3. These modifications result in decreased affinity for IGF-binding proteins, offering a prolonged half-life and enhanced receptor activation compared to recombinant IGF-1. In preclinical research, this peptide is employed to investigate signaling pathways associated with cellular proliferation, muscle cell differentiation, anabolic recovery, and fat metabolism. It is intended solely for laboratory studies and other research applications.

For Research Use Only – Not for Human Consumption.

Sizes

View COA: 02092621

Liv Pure Peptides Products: Igf-1lr3 1mg

At Liv Pure Peptides, innovation meets purity. Our advanced research and rigorous quality standards deliver breakthrough peptide solutions for better health and science.

Shop Products

Products

Pages

Legal

Newsletter Signup

YOU MUST BE OVER 21 YEARS OLD TO USE THIS WEBSITE.

All products provided by Liv Pure are intended solely for in‑vitro laboratory research purposes. These materials are expressly forbidden for any form of human or animal use, ingestion, or administration, and all products are sold strictly for research, laboratory, or analytical purposes – not for human consumption.

The products offered on this platform are not formulated, designed, or intended to diagnose, cure, mitigate, treat, or prevent any diseases or medical conditions. Additionally, these statements have not been evaluated by the Food and Drug Administration, and our products are not intended to diagnose, treat, cure, or prevent any disease.

All products are for Research and Development use only and are not for human consumption.

Liv Pure is a chemical supplier; LIV Pure Peptides is not a compounding pharmacy or chemical compounding facility as defined under Section 503A of the Federal Food, Drug, and Cosmetic Act, nor is it an outsourcing facility as defined under Section 503B of the Act.